Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
hVIVO plc
HVOCurrent price
29.3 GBX
+0.35 GBX (+1.21%)
Last closed
28.5 GBX
Company
–
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
London Exchange
Capitalization
191 802 769 GBX
Yield for 12 month
+50.06 %
1Y
3Y
5Y
10Y
15Y
HVO
hVIVO plc operates as a pharmaceutical service and contract research company in the United Kingdom. The company is involved in testing of vaccines and antivirals using human challenge clinical trials; and offers laboratory services, including assay development, cell based assays, compound efficacy and VRM, field trial bio-logistics, molecular, and biomarker analysis services. It provides services to big pharma and biotech organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, influenza, COVID-19, hMPV, HRV, asthma, malaria, and COPD. In addition, it offers specialized virology and immunology laboratory, which offers a suite of services to support pre-clinical and clinical respiratory drug; and vaccine discovery and development. Further, the company provides preclinical and early clinical research services; sales and marketing services; data management; and statistics services, as well as drug development consultancy and services. The company was formerly known as Open Orphan Plc and changed its name to hVIVO plc in October 2022. hVIVO plc is headquartered in London, the United Kingdom. Address: 21 Plumbers Row, London, United Kingdom, E1 1EQ
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
2 759.46 GBXP/E ratio
9.4537Dividend Yield
0.7 %Current Year
+55 706 846 GBX
Last Year
+48 186 195 GBX
Current Quarter
+28 573 563 GBX
Last Quarter
+14 918 467 GBX
Current Year
+7 651 846 GBX
Last Year
+3 979 975 GBX
Current Quarter
+5 148 903 GBX
Last Quarter
+3 890 052 GBX
Key Figures HVO
1 year
3 years
5 years
10 years
EBITDA
11 054 323 GBX
Operating Margin TTM
PE Ratio
9.4537
Return On Assets TTM
9.58 %
PEG Ratio
–
Return On Equity TTM
59.09 %
Wall Street Target Price
2 759.46 GBX
Revenue TTM
58 314 084 GBX
Book Value
0.05 GBX
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-5.7 %
Dividend Yield
0.7 %
Gross Profit TTM
9 017 580 GBX
Earnings per share
0.03 GBX
Diluted Eps TTM
0.03 GBX
Most Recent Quarter
IV 2023
Quarterly Earnings Growth YOY
1357.3 %
Profit Margin
27.47 %
Dividend Analytics HVO
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History HVO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
18.04.2024
Forward Annual Dividend Yield
0.7 %
Last Split Factor
1:30
Payout Ratio
–
Last Split Date
14.12.2012
Dividend Date
–
Stock Valuation HVO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
9.4537
Forward PE
17.6367
Enterprise Value Revenue
2.6062
Price Sales TTM
3.2891
Enterprise Value EBITDA
9.5653
Price Book MRQ
4.9882
Financials HVO
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators HVO
For 52 weeks
16.54 GBX
31.58 GBX
50 Day MA
28.89 GBX
Shares Short Prior Month
–
200 Day MA
27.31 GBX
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart